More about

Interstitial Lung Disease

News
June 17, 2022
5 min read
Save

‘You’re not alone’: What rheumatologists need to know about ILD, PAH in scleroderma

‘You’re not alone’: What rheumatologists need to know about ILD, PAH in scleroderma

Interstitial lung disease and pulmonary arterial hypertension associated with scleroderma often require consultations and co-management with physicians outside of rheumatology.

News
June 02, 2022
2 min read
Save

Top news of May: Long COVID, new IPF guideline, highlights from ATS and more

Top news of May: Long COVID, new IPF guideline, highlights from ATS and more

The Healio Editors compiled the most-read news in pulmonology posted in May.

News
May 24, 2022
1 min read
Save

FDA approves inhaled treprostinil for treatment of PAH, pulmonary hypertension-ILD

FDA approves inhaled treprostinil for treatment of PAH, pulmonary hypertension-ILD

United Therapeutics Corp. announced that the FDA has approved the Tyvaso dry powder inhaler for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease to improve exercise ability.

News
May 16, 2022
2 min read
Save

ATS issues new clinical practice guideline on IPF, progressive fibrotic ILDs

ATS issues new clinical practice guideline on IPF, progressive fibrotic ILDs

SAN FRANCISCO — A session at the American Thoracic Society International Conference highlighted a new clinical practice guideline addressing idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults.

News
May 14, 2022
2 min read
Save

Sjögren’s syndrome ‘not curable, but certainly treatable’ with available therapies

Sjögren’s syndrome ‘not curable, but certainly treatable’ with available therapies

DESTIN, Fla. — Although not currently curable, the symptoms of Sjögren’s syndrome, like dry eyes and dry mouth, can be effectively managed using a variety of therapies, said a speaker said at the Congress of Clinical Rheumatology East 2022 meeting.

News
May 11, 2022
1 min read
Save

Cough-specific quality of life may predict disease progression in ILD

Cough-specific quality of life may predict disease progression in ILD

Cough-specific quality of life was independently associated with respiratory hospitalization, mortality and lung transplantation among patients with interstitial lung disease, researchers reported in Chest.

News
May 02, 2022
2 min read
Save

COVID-19 vaccination may cause acute IPF exacerbation

COVID-19 vaccination may cause acute IPF exacerbation

Immune responses to COVID-19 vaccinations may trigger acute exacerbations in idiopathic pulmonary fibrosis among susceptible patients, according to data published in the American Journal of Respiratory and Critical Care Medicine.

News
March 22, 2022
13 min read
Save

Two steps forward, one step back: Hunting for a game-changer in scleroderma

Two steps forward, one step back: Hunting for a game-changer in scleroderma

The last 3 years of drug development in scleroderma have come to represent everything that ails the current pipeline for that disease.

News
March 16, 2022
2 min read
Save

Nintedanib has greater impact on SSc-ILD in patients without cough, dyspnea at baseline

Nintedanib has greater impact on SSc-ILD in patients without cough, dyspnea at baseline

Nintedanib reduces the rate of forced vital capacity decline more significantly in patients with systemic sclerosis-associated interstitial lung disease who reported no dyspnea or cough at baseline, data show.

News
February 28, 2022
1 min read
Save

Prevalence, incidence of idiopathic pulmonary fibrosis up over 10 years among US veterans

Prevalence, incidence of idiopathic pulmonary fibrosis up over 10 years among US veterans

In the past decade, the incidence of idiopathic pulmonary fibrosis nearly tripled and prevalence more than doubled among U.S. veterans, according to an analysis published in the Annals of the American Thoracic Society.

View more